Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.

Potential subjects were excluded if they had had previous glaucoma surgery or laser and also if intraocular surgery or additional SLT procedures were performed after the first treatment.

Legislation under consideration in Trenton could modernize the scope of access to modern eye care in New Jersey.

OC134 is an eye drop medicine candidate indicated for the topical treatment of moderate to severe allergic conjunctivitis, a condition for which a suitable non-steroidal topical ocular treatment, does ...

Many eye conditions can be easily treated if those at risk undergo regular eye examinations, and are informed about good ...

Topical medications remain the cornerstone of treatment for ocular diseases including infections, uveitic diseases, ocular hypertension and glaucoma ... number of all eye drops used by the ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

Cataracts are a common yet often misunderstood eye condition and remain one of the leading causes of vision impairment ...